Abstract
A new device called the Pivot-TR system was designed to treat tricuspid regurgitation with a novel spacer crossing the valve vertically. Its unique atraumatic anchoring system composed of both the elephant long nose and the inferior vena cava spiral anchor, in addition to the relatively easy implantation mechanism, enabled easy retrieval of the system later on. The system showed promising feasibility and safety results in this swine-based animal experiment, which should encourage human translation study.
Abstract as published in JACC. Basic to translational science, 2022;7(12):1249-1261, reproduced without changes (source: PubMed PMID 36644275). Read the full article on the publisher's site.
Related publications
CCI 2026 · Clinical
Safety and Efficacy of Pivot-Bridge for Severe Functional Tricuspid Regurgitation: The First-in-Human Experiences
View detailsEuroIntervention 2026 · Clinical
A novel spacer for transcatheter treatment of tricuspid regurgitation
View detailsKCJ 2025 · Clinical
